CN102166327A - Preparation method of Chinese medicine for treating liver-stagnation spleen-deficiency hyperthyroidism - Google Patents
Preparation method of Chinese medicine for treating liver-stagnation spleen-deficiency hyperthyroidism Download PDFInfo
- Publication number
- CN102166327A CN102166327A CN2010105509537A CN201010550953A CN102166327A CN 102166327 A CN102166327 A CN 102166327A CN 2010105509537 A CN2010105509537 A CN 2010105509537A CN 201010550953 A CN201010550953 A CN 201010550953A CN 102166327 A CN102166327 A CN 102166327A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- hyperthyroidism
- spleen
- liver
- deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 206010020850 Hyperthyroidism Diseases 0.000 title claims abstract description 31
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 229940126678 chinese medicines Drugs 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims abstract description 5
- 210000004185 liver Anatomy 0.000 claims description 29
- 241000195474 Sargassum Species 0.000 claims description 9
- 241000244155 Taenia Species 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 7
- 235000012239 silicon dioxide Nutrition 0.000 claims description 7
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 8
- 238000000034 method Methods 0.000 abstract description 3
- 208000024891 symptom Diseases 0.000 abstract description 3
- 208000001871 Tachycardia Diseases 0.000 abstract description 2
- 230000002045 lasting effect Effects 0.000 abstract description 2
- 230000006794 tachycardia Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000675108 Citrus tangerina Species 0.000 abstract 2
- 229940126673 western medicines Drugs 0.000 abstract 2
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 241001127714 Amomum Species 0.000 abstract 1
- 241000237528 Arcidae Species 0.000 abstract 1
- 241000512259 Ascophyllum nodosum Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 206010006895 Cachexia Diseases 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 241001061906 Caragana Species 0.000 abstract 1
- 244000183685 Citrus aurantium Species 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 241000220457 Crotalaria Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000075634 Cyperus rotundus Species 0.000 abstract 1
- 241000935235 Fritillaria meleagris Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 206010033557 Palpitations Diseases 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 241001409305 Siraitia Species 0.000 abstract 1
- 206010044565 Tremor Diseases 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000026500 emaciation Diseases 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 239000005495 thyroid hormone Substances 0.000 abstract 1
- 229940036555 thyroid hormone Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 description 22
- 210000000952 spleen Anatomy 0.000 description 19
- 206010062717 Increased upper airway secretion Diseases 0.000 description 17
- 208000026435 phlegm Diseases 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 230000001737 promoting effect Effects 0.000 description 12
- 210000003734 kidney Anatomy 0.000 description 9
- 238000010792 warming Methods 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000004087 circulation Effects 0.000 description 6
- 208000004880 Polyuria Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 210000002216 heart Anatomy 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 210000001685 thyroid gland Anatomy 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 206010000060 Abdominal distension Diseases 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 206010020880 Hypertrophy Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940034208 thyroxine Drugs 0.000 description 2
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- KNAHARQHSZJURB-UHFFFAOYSA-N Propylthiouracile Chemical compound CCCC1=CC(=O)NC(=S)N1 KNAHARQHSZJURB-UHFFFAOYSA-N 0.000 description 1
- 206010037083 Prurigo Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047115 Vasculitis Diseases 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000004090 etiopathogenesis Effects 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 229960002662 propylthiouracil Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000003488 releasing hormone Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105509537A CN102166327B (en) | 2010-11-19 | 2010-11-19 | Preparation method of traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type hyperthyroidism |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105509537A CN102166327B (en) | 2010-11-19 | 2010-11-19 | Preparation method of traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type hyperthyroidism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102166327A true CN102166327A (en) | 2011-08-31 |
| CN102166327B CN102166327B (en) | 2012-05-09 |
Family
ID=44487770
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105509537A Expired - Fee Related CN102166327B (en) | 2010-11-19 | 2010-11-19 | Preparation method of traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type hyperthyroidism |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102166327B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1915407A (en) * | 2005-09-01 | 2007-02-21 | 任翠兰 | Medicinal liquor |
-
2010
- 2010-11-19 CN CN2010105509537A patent/CN102166327B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1915407A (en) * | 2005-09-01 | 2007-02-21 | 任翠兰 | Medicinal liquor |
Non-Patent Citations (1)
| Title |
|---|
| 《河南中医》 20051231 詹世超; 等 甲亢汤治疗甲状腺机能亢进78例 38 1 第25卷, 第11期 2 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102166327B (en) | 2012-05-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103316208B (en) | Traditional Chinese medicine preparation with the functions of nourishing qi and nourishing blood, anti-aging, and prolonging life | |
| CN103495040B (en) | Traditional Chinese medicine composition for treating reflux esophagitis and preparation method of granule formulation thereof | |
| CN104225441A (en) | Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition | |
| CN1589881A (en) | Chinese medicinal prescription for treating gastropathy | |
| CN102166310B (en) | Preparation method of traditional Chinese medicine for treating liver and kidney Yin deficiency type hyperthyroidism | |
| CN103550687B (en) | A kind of Chinese medicine composition for the treatment of the hepatic and renal YIN deficiency | |
| CN1278718C (en) | Traditional Chinese medicine compound preparation for preventing and treating intestinal adhesion and preparing method | |
| CN102166309B (en) | Preparation method of traditional Chinese medicine for curing middle energizer intrinsic heat type hyperthyroidism | |
| CN104107348A (en) | Chinese herbal medicine for blood sugar reducing, and administration method thereof | |
| CN102166311B (en) | Preparation method of Chinese medicine for treating spleen-deficiency sthenic liver-energy hyperthyroidism | |
| CN102166326B (en) | Preparation method of traditional Chinese medicine for treating liver depression and kidney deficiency type hyperthyroidism | |
| CN107308353A (en) | A kind of Chinese medicine preparation for treating diabetes | |
| CN105535511A (en) | Stomach harmonizing and pain relieving granule and preparation method thereof | |
| CN1248727C (en) | Insensitive impediment capsule and its manufacturing method | |
| CN102166327B (en) | Preparation method of traditional Chinese medicine for treating liver-stagnation and spleen-deficiency type hyperthyroidism | |
| CN109289033A (en) | A kind of Chinese medicine composition that treating cold-dampness stomach trouble and preparation method | |
| CN105963608A (en) | Traditional Chinese medicine for treating type 2 diabetes mellitus | |
| CN102166325B (en) | Preparation method of Chinese medicine for treating hyperthyroidism | |
| CN105663851A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN104998074A (en) | Traditional Chinese medicine for treating gastropathy and preparation method thereof | |
| CN111084820A (en) | Traditional Chinese medicine composition for treating chronic kidney disease malnutrition and preparation and application thereof | |
| CN102935214A (en) | Traditional Chinese medicinal composition for treating uremia | |
| CN102961696A (en) | Chinese medicinal composition for treating diabetic nephropathy edema | |
| CN105920440A (en) | Chinese medicinal composition for treating edema | |
| CN105727076A (en) | Traditional Chinese medicine composition for treating chronic diarrhea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: ZHENG TIANYING Free format text: FORMER OWNER: LI DERU Effective date: 20120216 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zheng Tiancheng Inventor after: Xue Qing Inventor before: Li Deru |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250061 JINAN, SHANDONG PROVINCE TO: 250012 JINAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI DERU TO: ZHENG TIANYING XUE QING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20120216 Address after: 250012 Center for chemotherapy, Qilu Hospital,, 107 west road, Shandong, Ji'nan, China Applicant after: Zheng Tiancheng Address before: 250061, No. 3, No. ten, No. 17531, 2-201, Shandong, Ji'nan Applicant before: Li Deru |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120509 Termination date: 20121119 |

